Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.
Press releases published on August 11, 2025
CompTIA explores the cybersecurity viability trifecta at upcoming TechNet Augusta conference
GlobeNewswire
·
August 11, 2025
DOWNERS GROVE, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Key insights into how people, data and artificial intelligence (AI) can work together to elevate cybersecurity readiness is the focus of a CompTIA Learning Solutions Series session at this month’s …
Oragenics Q2 2025 Shareholder Update
GlobeNewswire
·
August 11, 2025
Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering biotechnology company striving to …
VivoPower to Procure Underlying 211 million XRP Position Worth $696 million Through Budgeted Initial $100 million Acquisition of Ripple Shares
GlobeNewswire
·
August 11, 2025
Backed by investors including Andreessen Horowitz and Google Ventures, Ripple Labs (Ripple) holds 41 billion XRP tokens, representing approximately 41% of all XRP tokens on issue VivoPower will become the first and only U.S.-listed company to provide …
AITX Extinguishes Almost $5 Million of Debt, Targets FY Q2 Profit
GlobeNewswire
·
August 11, 2025
Strategic Debt Settlement Bolsters Balance Sheet; Company on Track to Report Net Profitability for Q2 FY 2026 Detroit, Michigan, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global …
Wix Announces $200 Million Increase to Share Repurchase Program
GlobeNewswire
·
August 11, 2025
Wix.com Ltd. (NASDAQ: WIX) (“Wix,” the “Company,” “we” or “our”) today announced that its Board of Directors (the “Board”) has authorized an increase to its program to repurchase the Company’s securities (ordinary shares and/or convertible notes) by an …
Physiotherapy Equipment Market to Surge to USD 9.45 Billion by 2029 | MarketsandMarkets™.
GlobeNewswire
·
August 11, 2025
Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The global physiotherapy equipment market is projected to expand from USD 6.70 billion in 2024 to USD 9.45 billion by 2029, registering a CAGR of 7.1%. What’s driving this growth? A convergence of …
Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
GlobeNewswire
·
August 11, 2025
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced selection of a …
Fluent, Inc. to Attend 45th Annual Canaccord Genuity Growth Conference
GlobeNewswire
·
August 11, 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leader in commerce media, today announced that Don Patrick, Chief Executive Officer, will attend the 45th Annual Canaccord Genuity Growth Conference on Wednesday, August 13, 2025, …
SEALSQ Unveils SEALQuantum.com Innovation Lab Progress, Expanding into AI to Anticipate the Convergence with Quantum and Cybersecurity
GlobeNewswire
·
August 11, 2025
Geneva, Switzerland, Aug. 11, 2025 (GLOBE NEWSWIRE) -- With a total $30 Million investment capacity, SEALSQ shares strategic updates on ColibriTD and IC’Alps SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a leading provider of Semiconductors, PKI, …
EverQuote Announces $21 Million Repurchase of Shares from Link Ventures and Affiliated Entities Controlled by Chairman and Co-Founder, David Blundin
GlobeNewswire
·
August 11, 2025
Enables EverQuote to efficiently execute a portion of its $50 million Share Repurchase Program Mr. Blundin remains EverQuote’s Chairman and largest shareholder CAMBRIDGE, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading …
Mevolaxy Announces Its Market Shift from DeFi Farming to MEV Staking
GlobeNewswire
·
August 11, 2025
Los Angeles, CA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Mevolaxy today announced its strategic positioning as a leading player in the accelerating transition from DeFi farming to advanced MEV staking strategies. With blockchain automation and more sophisticated …
Full Alliance Group’s Qubitera Holdings Expands Quant Blockchain Healthcare Development Roadmap
GlobeNewswire
·
August 11, 2025
TAMPA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its subsidiary, Qubitera Holdings Inc., has released a comprehensive five-phase technical roadmap to deploy a post-quantum cryptography (PQC)-based …
Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
GlobeNewswire
·
August 11, 2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results …
CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 11, 2025
Reported 32-week data from Phase 2b RewinD-LB Trial Extension phase showing neflamapimod treatment resulted in a substantial reduction in clinically significant worsening compared to control arm over 32 weeks, which improved further among patients who have …
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin
GlobeNewswire
·
August 11, 2025
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated …
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results
GlobeNewswire
·
August 11, 2025
- Released positive topline data from the VIRAGE Phase 2b study of VCN-01 (zabilugene almadenorepvec); expanded data to be presented at the European Society for Medical Oncology (ESMO) 2025 Congress in October - - VCN-01 demonstrates potential in …
GBT Technologies Intends to Rebrand as Wertheim & Company; Craig Marshak Appointed CEO; Emil Assentato Joins as Strategic Investor
GlobeNewswire
·
August 11, 2025
WEST HOLLYWOOD, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC Pink: GTCH) (“GBT” or the “Company”) today announced its intention to change its corporate name to Wertheim …
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
GlobeNewswire
·
August 11, 2025
4D-150 Phase 3 program in wet AMD advancing ahead of plan, with expected 4FRONT-1 data readout accelerated to H1 2027 from H2 2027 and 4FRONT-2 initiated ahead of schedule Presented positive 60-week results from 4D-150 SPECTRA clinical trial in DME …
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2025
GlobeNewswire
·
August 11, 2025
- Se han publicado datos preliminares positivos del estudio de Fase 2b de VIRAGE de VCN-01 (zabilugene almadenorepvec); los datos ampliados se presentarán en el Congreso de la European Society for Medical Oncology (ESMO) de 2025 que tendrá lugar en octubre …
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 11, 2025
CONSHOHOCKEN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, Aug. 12, 2025 at 10:30 A.M. EDT. The …